Zymeworks (ZYME) Goodwill & Intangibles (2021 - 2026)
Zymeworks (ZYME) reported Goodwill & Intangibles of $13.2 million for Q1 2026, down 14.23% on a YoY basis from $15.4 million in Q1 2025, and down 1.32% sequentially from $13.4 million in Q4 2025.
Zymeworks (ZYME) Goodwill & Intangibles (2021 - 2026) Analysis & Trends
Zymeworks (ZYME) has 6 years of Goodwill & Intangibles data on file, last reported at $13.2 million in Q1 2026.
- For the quarter ending Q1 2026, Goodwill & Intangibles fell 14.23% year-over-year to $13.2 million; the trailing twelve-month figure through Mar 2026 stood at $13.2 million (down 14.23% YoY), and the FY2025 full-year result was $13.4 million, down 19.44% from the prior year.
- Goodwill & Intangibles eased to $13.2 million in Q1 2026, from $13.4 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $29.6 million in Q4 2022 to a low of $12.4 million in Q2 2024.
- A 5-year average of $18.4 million and a median of $18.4 million in 2024 frame the typical range for Goodwill & Intangibles.
- Across the five-year window, Goodwill & Intangibles tumbled 36.35% in 2024 and climbed 13.79% in 2025, its largest moves.
- Tracing ZYME's Goodwill & Intangibles over 5 years: stood at $29.6 million in 2022, then plunged by 33.64% to $19.7 million in 2023, then decreased by 15.66% to $16.6 million in 2024, then dropped by 19.44% to $13.4 million in 2025, then dropped by 1.32% to $13.2 million in 2026.
- Business Quant data shows ZYME's Goodwill & Intangibles at $13.2 million in Q1 2026, $13.4 million in Q4 2025, and $13.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Zymeworks | 1.70 Bn | 1.34 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.19 Mn |
| Dec 31, 2025 | 13.37 Mn |
| Sep 30, 2025 | 13.41 Mn |
| Jun 30, 2025 | 14.06 Mn |
| Mar 31, 2025 | 15.38 Mn |
| Dec 31, 2024 | 16.59 Mn |
| Sep 30, 2024 | 18.42 Mn |
| Jun 30, 2024 | 12.36 Mn |
| Mar 31, 2024 | 19.44 Mn |
| Dec 31, 2023 | 19.67 Mn |
| Sep 30, 2023 | 20.02 Mn |
| Jun 30, 2023 | 19.41 Mn |
| Mar 31, 2023 | 29.64 Mn |
| Dec 31, 2022 | 29.64 Mn |
| Sep 30, 2022 | 21.04 Mn |
| Dec 31, 2021 | 29.64 Mn |